Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addition, the company offers consultations, diagnoses, and non-surgical treatments; and sells opticals, contact lenses and accessories, and eye care related pharmaceutical products. Dr. Agarwal's Health Care Limited was incorporated in 2010 and is based in Chennai, India.
| Current Price | ₹475.00 |
|---|---|
| Market Cap | ₹14,767 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 112 |
| Return on Equity | 8.31% |
| 52-Week Range | ₹401.00 – ₹567.75 |
| Beta (1Y) | 0.27 |
| Revenue | ₹614 Cr |
|---|---|
| Net Profit | ₹55 Cr |
| EPS (Basic) | ₹1.43 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Eye Care Related Sales and Services-100%
Dr. Agarwal's Health Care Limited is trading at ₹475.00, with a market capitalisation of ₹14,767 Cr.
Dr. Agarwal's Health Care Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Dr. Agarwal's Health Care Limited has a P/E of 112 and a return on equity of 8.31%.
In Q1 FY27, Dr. Agarwal's Health Care Limited reported revenue of ₹614 Cr and net profit of ₹55 Cr, with basic EPS of ₹1.43 (consolidated, parsed from the company's exchange filing).